Intra-Cellular Therapies Ownership 2024 | Who Owns Intra-Cellular Therapies Now?
Institutional Ownership
10.48%
Insider Ownership
2.34%
Retail Ownership
87.18%
Institutional Holders
138.00
Intra-Cellular Therapies Institutional Shareholders
Institutional Shareholders by % of Total Shares
| Name | % Total Shares | % Total Assets | Current Shares | Change Amount | Change % | Market Value | Date |
|---|---|---|---|---|---|---|---|
| FMR LLC | 11.60% | 0.05% | 11,237,798 | 43,185 | 0.39% | 769,676,818 | Jun 30, 2024 |
| VANGUARD GROUP INC | 9.92% | 0.01% | 9,606,906 | 380,925 | 4.13% | 657,976,992 | Jun 30, 2024 |
| BLACKROCK INC. | 6.53% | 0.01% | 6,321,619 | -1,756,139 | -21.74% | 432,967,685 | Jun 30, 2024 |
| WASATCH ADVISORS LP | 3.84% | 1.36% | 3,718,237 | -136,510 | -3.54% | 254,662,052 | Jun 30, 2024 |
| JPMORGAN CHASE & CO | 3.55% | 0.02% | 3,435,232 | 1,679,284 | 95.63% | 235,279,071 | Jun 30, 2024 |
| AVORO CAPITAL ADVISORS LLC | 3.10% | 2.74% | 3,000,000 | 525,000 | 21.21% | 205,470,000 | Jun 30, 2024 |
| INVESCO LTD. | 3.03% | 0.04% | 2,937,354 | 864,373 | 41.70% | 201,179,375 | Jun 30, 2024 |
| BELLEVUE GROUP AG | 2.55% | 2.75% | 2,471,285 | -348,197 | -12.35% | 169,258,310 | Jun 30, 2024 |
| NORGES BANK | 2.01% | 0.02% | 1,943,730 | 1,943,730 | 100.00% | 133,126,068 | Jun 30, 2024 |
| STATE STREET CORP | 1.86% | 0.01% | 1,802,251 | -438,444 | -19.57% | 123,436,171,000 | Jun 30, 2024 |
| CLEARBRIDGE INVESTMENTS, LLC | 1.78% | 0.10% | 1,721,610 | -22,941 | -1.31% | 117,913,038 | Jun 30, 2024 |
| PERCEPTIVE ADVISORS LLC | 1.77% | 2.79% | 1,716,407 | 661,052 | 62.64% | 117,556,715 | Jun 30, 2024 |
| GEODE CAPITAL MANAGEMENT, LLC | 1.74% | 0.01% | 1,686,173 | -379,125 | -18.36% | 115,516,463 | Jun 30, 2024 |
| FRANKLIN RESOURCES INC | 1.65% | 0.03% | 1,597,631 | -21,932 | -1.35% | 109,421,716 | Jun 30, 2024 |
| SUVRETTA CAPITAL MANAGEMENT, LLC | 1.62% | 3.94% | 1,565,996 | 606,798 | 63.26% | 107,255,066 | Jun 30, 2024 |
| DEEP TRACK CAPITAL, LP | 1.59% | 3.14% | 1,537,922 | 37,922 | 2.53% | 105,332,278 | Jun 30, 2024 |
| HOLOCENE ADVISORS, LP | 1.53% | 0.42% | 1,479,675 | 570,585 | 62.76% | 101,342,941 | Jun 30, 2024 |
| PRICE T ROWE ASSOCIATES INC /MD/ | 1.47% | 0.01% | 1,428,410 | 224,442 | 18.64% | 97,832,000 | Jun 30, 2024 |
| ALYESKA INVESTMENT GROUP, L.P. | 1.44% | 0.55% | 1,394,532 | 1,142,612 | 453.56% | 95,511,497 | Jun 30, 2024 |
| GW&K INVESTMENT MANAGEMENT, LLC | 1.44% | 0.87% | 1,393,978 | -204,986 | -12.82% | 95,473,000 | Jun 30, 2024 |
Intra-Cellular Therapies's largest institutional shareholder is FMR LLC, holding 11.60% of the company's total share outstanding, currently valued at $769.68M. The top 10 institutional shareholders own together 47.97% of the company.
Institutional Shareholders by % of Total Assets
| Name | % Total Shares | % Total Assets | Current Shares | Change Amount | Change % | Market Value | Date |
|---|---|---|---|---|---|---|---|
| ALTIUM CAPITAL MANAGEMENT LP | 0.20% | 5.39% | 193,000 | 80,000 | 70.80% | 13,218,570 | Jun 30, 2024 |
| SUVRETTA CAPITAL MANAGEMENT, LLC | 1.62% | 3.94% | 1,565,996 | 606,798 | 63.26% | 107,255,066 | Jun 30, 2024 |
| FIRST TURN MANAGEMENT, LLC | 0.36% | 3.87% | 347,343 | 140,636 | 68.04% | 23,789,522 | Jun 30, 2024 |
| DCF ADVISERS, LLC | 0.10% | 3.55% | 100,507 | 3,650 | 3.77% | 6,883,724 | Jun 30, 2024 |
| DEEP TRACK CAPITAL, LP | 1.59% | 3.14% | 1,537,922 | 37,922 | 2.53% | 105,332,278 | Jun 30, 2024 |
| SILVERARC CAPITAL MANAGEMENT, LLC | 0.20% | 3.11% | 192,345 | 157,538 | 452.60% | 13,173,709 | Jun 30, 2024 |
| ARTIA GLOBAL PARTNERS LP | 0.22% | 2.87% | 216,519 | 6,423 | 3.06% | 14,829,386 | Jun 30, 2024 |
| PERCEPTIVE ADVISORS LLC | 1.77% | 2.79% | 1,716,407 | 661,052 | 62.64% | 117,556,715 | Jun 30, 2024 |
| BELLEVUE GROUP AG | 2.55% | 2.75% | 2,471,285 | -348,197 | -12.35% | 169,258,310 | Jun 30, 2024 |
| AVORO CAPITAL ADVISORS LLC | 3.10% | 2.74% | 3,000,000 | 525,000 | 21.21% | 205,470,000 | Jun 30, 2024 |
| TANG CAPITAL MANAGEMENT LLC | 0.31% | 2.09% | 300,000 | 150,000 | 100.00% | 20,547,000 | Jun 30, 2024 |
| PRIVIUM FUND MANAGEMENT B.V. | 0.12% | 2.06% | 117,983 | 9,100 | 8.36% | 8,086,555 | Jun 30, 2024 |
| 1492 CAPITAL MANAGEMENT LLC | 0.05% | 2.06% | 53,120 | 17,857 | 50.64% | 3,638,189 | Jun 30, 2024 |
| SYSTEMATIC PORTFOLIOS LLC | 0.00% | 1.89% | 3,973 | 3,973 | 100.00% | 272,111 | Jun 30, 2024 |
| PARKMAN HEALTHCARE PARTNERS LLC | 0.19% | 1.70% | 185,028 | 115,136 | 164.73% | 12,672,568 | Jun 30, 2024 |
| HEALTHINVEST PARTNERS AB | 0.04% | 1.50% | 35,841 | -2,209 | -5.81% | 2,454,750 | Jun 30, 2024 |
| LISANTI CAPITAL GROWTH, LLC | 0.09% | 1.36% | 82,875 | 29,590 | 55.53% | 5,676,109 | Jun 30, 2024 |
| WASATCH ADVISORS LP | 3.84% | 1.36% | 3,718,237 | -136,510 | -3.54% | 254,662,052 | Jun 30, 2024 |
| MOODY ALDRICH PARTNERS LLC | 0.10% | 1.32% | 99,012 | 99,012 | 100.00% | 6,781,332 | Jun 30, 2024 |
| GENERAL AMERICAN INVESTORS CO INC | 0.27% | 1.25% | 261,780 | 1,341 | 0.51% | 17,929,312 | Jun 30, 2024 |
The largest Intra-Cellular Therapies shareholder by % of total assets is ALTIUM CAPITAL MANAGEMENT LP. The company owns 193.00K shares of Intra-Cellular Therapies (ITCI), representing 5.39% of its total assets.
Institutional Buyers
| Name | % Total Shares | % Total Assets | Current Shares | Change Amount | Change % | Market Value | Date |
|---|---|---|---|---|---|---|---|
| NORGES BANK | 2.01% | 0.02% | 1,943,730 | 1,943,730 | 100.00% | 133,126,068 | Jun 30, 2024 |
| JPMORGAN CHASE & CO | 3.55% | 0.02% | 3,435,232 | 1,679,284 | 95.63% | 235,279,071 | Jun 30, 2024 |
| ALYESKA INVESTMENT GROUP, L.P. | 1.44% | 0.55% | 1,394,532 | 1,142,612 | 453.56% | 95,511,497 | Jun 30, 2024 |
| WESTFIELD CAPITAL MANAGEMENT CO LP | 1.08% | 0.35% | 1,042,862 | 1,042,862 | 100.00% | 71,425,618 | Jun 30, 2024 |
| INVESCO LTD. | 3.03% | 0.04% | 2,937,354 | 864,373 | 41.70% | 201,179,375 | Jun 30, 2024 |
| PERCEPTIVE ADVISORS LLC | 1.77% | 2.79% | 1,716,407 | 661,052 | 62.64% | 117,556,715 | Jun 30, 2024 |
| SUVRETTA CAPITAL MANAGEMENT, LLC | 1.62% | 3.94% | 1,565,996 | 606,798 | 63.26% | 107,255,066 | Jun 30, 2024 |
| MILLENNIUM MANAGEMENT LLC | 0.92% | 0.03% | 889,102 | 606,358 | 214.45% | 60,894,596 | Jun 30, 2024 |
| HOLOCENE ADVISORS, LP | 1.53% | 0.42% | 1,479,675 | 570,585 | 62.76% | 101,342,941 | Jun 30, 2024 |
| AVORO CAPITAL ADVISORS LLC | 3.10% | 2.74% | 3,000,000 | 525,000 | 21.21% | 205,470,000 | Jun 30, 2024 |
| MARSHALL WACE, LLP | 0.52% | 0.05% | 499,015 | 499,015 | 100.00% | 34,177,537 | Jun 30, 2024 |
| HOOD RIVER CAPITAL MANAGEMENT LLC | 0.50% | 0.69% | 487,518 | 487,518 | 100.00% | 33,390,108 | Jun 30, 2024 |
| PICTET ASSET MANAGEMENT HOLDING SA | 1.30% | 0.10% | 1,255,076 | 434,546 | 52.96% | 85,960,155 | Jun 30, 2024 |
| VANGUARD GROUP INC | 9.92% | 0.01% | 9,606,906 | 380,925 | 4.13% | 657,976,992 | Jun 30, 2024 |
| POINT72 ASSET MANAGEMENT, L.P. | 0.57% | 0.10% | 554,186 | 380,420 | 218.93% | 37,956,199 | Jun 30, 2024 |
| DEUTSCHE BANK AG\ | 0.88% | 0.03% | 852,984 | 261,095 | 44.11% | 58,420,873 | Jun 30, 2024 |
| HRT FINANCIAL LP | 0.25% | 0.09% | 240,196 | 240,196 | 100.00% | 16,451,000 | Jun 30, 2024 |
| PRICE T ROWE ASSOCIATES INC /MD/ | 1.47% | 0.01% | 1,428,410 | 224,442 | 18.64% | 97,832,000 | Jun 30, 2024 |
| DRIEHAUS CAPITAL MANAGEMENT LLC | 0.22% | 0.14% | 215,439 | 215,439 | 100.00% | 14,755,417 | Jun 30, 2024 |
| QUBE RESEARCH & TECHNOLOGIES LTD | 0.29% | 0.03% | 278,574 | 190,196 | 215.21% | 19,079,533 | Jun 30, 2024 |
As of Jun 30 2024, Intra-Cellular Therapies's largest institutional buyer is NORGES BANK. The company purchased 1.94M stocks of ITCI, valued at $133.13M.
Institutional Sellers
| Name | % Total Shares | % Total Assets | Current Shares | Change Amount | Change % | Market Value | Date |
|---|---|---|---|---|---|---|---|
| BLACKROCK INC. | 6.53% | 0.01% | 6,321,619 | -1,756,139 | -21.74% | 432,967,685 | Jun 30, 2024 |
| AVIDITY PARTNERS MANAGEMENT LP | - | - | - | -600,000 | -100.00% | - | Jun 30, 2024 |
| MACQUARIE GROUP LTD | 1.04% | 0.08% | 1,011,266 | -451,114 | -30.85% | 69,261,866 | Jun 30, 2024 |
| STATE STREET CORP | 1.86% | 0.01% | 1,802,251 | -438,444 | -19.57% | 123,436,171,000 | Jun 30, 2024 |
| WELLINGTON MANAGEMENT GROUP LLP | 1.29% | 0.02% | 1,252,904 | -408,966 | -24.61% | 85,811,396 | Jun 30, 2024 |
| GEODE CAPITAL MANAGEMENT, LLC | 1.74% | 0.01% | 1,686,173 | -379,125 | -18.36% | 115,516,463 | Jun 30, 2024 |
| JANUS HENDERSON GROUP PLC | 0.04% | 0.00% | 40,161 | -361,196 | -89.99% | 2,747,625 | Jun 30, 2024 |
| BELLEVUE GROUP AG | 2.55% | 2.75% | 2,471,285 | -348,197 | -12.35% | 169,258,310 | Jun 30, 2024 |
| ASSENAGON ASSET MANAGEMENT S.A. | 0.35% | 0.05% | 342,843 | -306,974 | -47.24% | 23,481,317 | Jun 30, 2024 |
| AMERICAN CENTURY COMPANIES INC | 0.28% | 0.01% | 268,983 | -273,930 | -50.46% | 18,422,708 | Jun 30, 2024 |
| CAPTION MANAGEMENT, LLC | 0.00% | 0.00% | 618 | -266,162 | -99.77% | 42,327 | Jun 30, 2024 |
| NUVEEN ASSET MANAGEMENT, LLC | 0.59% | 0.01% | 567,824 | -251,851 | -30.73% | 38,890,266 | Jun 30, 2024 |
| FARALLON CAPITAL MANAGEMENT LLC | - | - | - | -231,000 | -100.00% | - | Jun 30, 2024 |
| LMR PARTNERS LLP | 0.01% | 0.00% | 7,600 | -221,000 | -96.68% | 520,524 | Jun 30, 2024 |
| ALLIANCEBERNSTEIN L.P. | 1.41% | 0.03% | 1,366,467 | -214,247 | -13.55% | 93,589,325 | Jun 30, 2024 |
| GW&K INVESTMENT MANAGEMENT, LLC | 1.44% | 0.87% | 1,393,978 | -204,986 | -12.82% | 95,473,000 | Jun 30, 2024 |
| AVIDITY PARTNERS MANAGEMENT LP | 0.41% | 1.16% | 400,000 | -200,000 | -33.33% | 27,396,000 | Jun 30, 2024 |
| GOLDMAN SACHS GROUP INC | 0.61% | 0.01% | 588,181 | -178,246 | -23.26% | 40,284,517 | Jun 30, 2024 |
| DEEP TRACK CAPITAL, LP | - | - | - | -175,400 | -100.00% | - | Jun 30, 2024 |
| GREAT POINT PARTNERS LLC | - | - | - | -150,000 | -100.00% | - | Jun 30, 2024 |
As of Jun 30 2024, Intra-Cellular Therapies's biggest institutional seller is BLACKROCK INC.. The company sold -1.76M shares of ITCI, valued at $432.97M.
Institutional New positions
| Name | % Total Shares | % Total Assets | Current Shares | Change Amount | Change % | Market Value | Date |
|---|---|---|---|---|---|---|---|
| NORGES BANK | 2.01% | 0.02% | 1,943,730 | 1,943,730 | 100.00% | 133,126,068 | Jun 30, 2024 |
| WESTFIELD CAPITAL MANAGEMENT CO LP | 1.08% | 0.35% | 1,042,862 | 1,042,862 | 100.00% | 71,425,618 | Jun 30, 2024 |
| HOOD RIVER CAPITAL MANAGEMENT LLC | 0.50% | 0.69% | 487,518 | 487,518 | 100.00% | 33,390,108 | Jun 30, 2024 |
| DRIEHAUS CAPITAL MANAGEMENT LLC | 0.22% | 0.14% | 215,439 | 215,439 | 100.00% | 14,755,417 | Jun 30, 2024 |
| MOODY ALDRICH PARTNERS LLC | 0.10% | 1.32% | 99,012 | 99,012 | 100.00% | 6,781,332 | Jun 30, 2024 |
| TWIN TREE MANAGEMENT, LP | 0.09% | 0.01% | 87,800 | 87,800 | 100.00% | 6,013,422 | Jun 30, 2024 |
| PALOMA PARTNERS MANAGEMENT CO | 0.07% | 0.14% | 70,040 | 70,040 | 100.00% | 4,797,040 | Jun 30, 2024 |
| LOMBARD ODIER ASSET MANAGEMENT (EUROPE) LTD | 0.06% | 0.19% | 60,000 | 60,000 | 100.00% | 4,109,400 | Jun 30, 2024 |
| MIRAE ASSET GLOBAL ETFS HOLDINGS LTD. | 0.05% | 0.01% | 50,437 | 50,437 | 100.00% | 3,454,430 | Jun 30, 2024 |
| GHISALLO CAPITAL MANAGEMENT LLC | 0.05% | 0.24% | 50,000 | 50,000 | 100.00% | 3,424,500 | Jun 30, 2024 |
| TREASURER OF THE STATE OF NORTH CAROLINA | 0.05% | 0.01% | 44,790 | 44,790 | 100.00% | 3,068,000 | Jun 30, 2024 |
| POINT72 HONG KONG LTD | 0.05% | 0.18% | 44,368 | 44,368 | 100.00% | 3,038,764 | Jun 30, 2024 |
| BAIRD FINANCIAL GROUP, INC. | 0.04% | 0.01% | 36,226 | 36,226 | 100.00% | 2,481,119 | Jun 30, 2024 |
| ALPINE GLOBAL MANAGEMENT, LLC | 0.04% | 0.42% | 35,300 | 35,300 | 100.00% | 2,417,697 | Jun 30, 2024 |
| SCIENTECH RESEARCH LLC | 0.04% | 0.50% | 35,270 | 35,270 | 100.00% | 2,415,642 | Jun 30, 2024 |
| POINT72 EUROPE (LONDON) LLP | 0.03% | 0.18% | 32,300 | 32,300 | 100.00% | 2,212,227 | Jun 30, 2024 |
| J. SAFRA SARASIN HOLDING AG | 0.03% | 0.04% | 31,369 | 31,369 | 100.00% | 2,148,463 | Jun 30, 2024 |
| SEVEN EIGHT CAPITAL, LP | 0.02% | 0.16% | 21,910 | 21,910 | 100.00% | 1,500,616 | Jun 30, 2024 |
| POINT72 (DIFC) LTD | 0.02% | 0.05% | 20,385 | 20,385 | 100.00% | 1,396,169 | Jun 30, 2024 |
| XTX TOPCO LTD | 0.02% | 0.12% | 20,220 | 20,220 | 100.00% | 1,384,868 | Jun 30, 2024 |
| SIMPLIFY ASSET MANAGEMENT INC. | 0.02% | 0.09% | 18,537 | 18,537 | 100.00% | 1,269,599 | Jun 30, 2024 |
| SUSQUEHANNA FUNDAMENTAL INVESTMENTS, LLC | 0.02% | 0.03% | 17,108 | 17,108 | 100.00% | 1,171,727 | Jun 30, 2024 |
| UBS OCONNOR LLC | 0.02% | 0.07% | 17,000 | 17,000 | 100.00% | 1,164,330 | Jun 30, 2024 |
| CENTERBOOK PARTNERS LP | 0.02% | 0.07% | 15,668 | 15,668 | 100.00% | 1,073,101 | Jun 30, 2024 |
| UBS OCONNOR LLC | 0.02% | 0.00% | 15,000 | 15,000 | 100.00% | 14,625 | Jun 30, 2024 |
| GLENMEDE TRUST CO NA | 0.01% | 0.00% | 12,758 | 12,758 | 100.00% | 873,795 | Jun 30, 2024 |
| OAK RIDGE INVESTMENTS LLC | 0.01% | 0.08% | 11,839 | 11,839 | 100.00% | 810,853 | Jun 30, 2024 |
| DYNAMIC TECHNOLOGY LAB PRIVATE LTD | 0.01% | 0.08% | 10,947 | 10,947 | 100.00% | 750,000 | Jun 30, 2024 |
| GHOST TREE CAPITAL, LLC | 0.01% | 0.21% | 10,000 | 10,000 | 100.00% | 684,900 | Jun 30, 2024 |
| MIRABELLA FINANCIAL SERVICES LLP | 0.01% | 0.05% | 9,630 | 9,630 | 100.00% | 659,559 | Jun 30, 2024 |
| ALBERTA INVESTMENT MANAGEMENT CORP | 0.01% | 0.01% | 9,600 | 9,600 | 100.00% | 657,504 | Jun 30, 2024 |
| LAURION CAPITAL MANAGEMENT LP | 0.01% | 0.01% | 9,270 | 9,270 | 100.00% | 634,902 | Jun 30, 2024 |
| MARYLAND STATE RETIREMENT & PENSION SYSTEM | 0.01% | 0.01% | 8,018 | 8,018 | 100.00% | 549,153 | Jun 30, 2024 |
| AIGEN INVESTMENT MANAGEMENT, LP | 0.01% | 0.10% | 7,785 | 7,785 | 100.00% | 533,195 | Jun 30, 2024 |
| UTAH RETIREMENT SYSTEMS | 0.01% | 0.00% | 5,500 | 5,500 | 100.00% | 376,695 | Jun 30, 2024 |
| GOTHAM ASSET MANAGEMENT, LLC | 0.01% | 0.00% | 5,286 | 5,286 | 100.00% | 362,038 | Jun 30, 2024 |
| SOUND VIEW WEALTH ADVISORS GROUP, LLC | 0.01% | 0.03% | 4,912 | 4,912 | 100.00% | 336,423 | Jun 30, 2024 |
| OMERS ADMINISTRATION CORP | 0.00% | 0.00% | 4,500 | 4,500 | 100.00% | 308,205 | Jun 30, 2024 |
| AVANTAX ADVISORY SERVICES, INC. | 0.00% | 0.00% | 4,424 | 4,424 | 100.00% | 303,000 | Jun 30, 2024 |
| ALPHAMARK ADVISORS, LLC | 0.00% | 0.10% | 4,219 | 4,219 | 100.00% | 289,000 | Jun 30, 2024 |
| PALLAS CAPITAL ADVISORS LLC | 0.00% | 0.01% | 4,120 | 4,120 | 100.00% | 308,753 | Jun 30, 2024 |
| PEAK6 INVESTMENTS LLC | 0.00% | 0.00% | 4,049 | 4,049 | 100.00% | 277,316 | Jun 30, 2024 |
| RESOURCES INVESTMENT ADVISORS, LLC. | 0.00% | 0.00% | 4,003 | 4,003 | 100.00% | 274,165 | Jun 30, 2024 |
| SYSTEMATIC PORTFOLIOS LLC | 0.00% | 1.89% | 3,973 | 3,973 | 100.00% | 272,111 | Jun 30, 2024 |
| ARROWSTREET CAPITAL, LIMITED PARTNERSHIP | 0.00% | 0.00% | 3,906 | 3,906 | 100.00% | 268,000 | Jun 30, 2024 |
| QUANTBOT TECHNOLOGIES LP | 0.00% | 0.01% | 3,782 | 3,782 | 100.00% | 259,029 | Jun 30, 2024 |
| ATRIA INVESTMENTS, INC | 0.00% | 0.00% | 3,640 | 3,640 | 100.00% | 249,304 | Jun 30, 2024 |
| TEZA CAPITAL MANAGEMENT LLC | 0.00% | 0.03% | 3,417 | 3,417 | 100.00% | 234,030 | Jun 30, 2024 |
| CLOUGH CAPITAL PARTNERS L P | 0.00% | 0.03% | 3,400 | 3,400 | 100.00% | 232,866 | Jun 30, 2024 |
| WEALTH ENHANCEMENT ADVISORY SERVICES, LLC | 0.00% | 0.00% | 3,085 | 3,085 | 100.00% | 211,292 | Jun 30, 2024 |
| DIAMETRIC CAPITAL, LP | 0.00% | 0.11% | 3,077 | 3,077 | 100.00% | 210,743 | Jun 30, 2024 |
| NOMURA HOLDINGS INC | 0.00% | 0.00% | 3,005 | 3,005 | 100.00% | 205,812 | Jun 30, 2024 |
| COREBRIDGE FINANCIAL, INC. | 0.00% | 0.00% | 2,047 | 2,047 | 100.00% | 140,199 | Jun 30, 2024 |
| CETERA TRUST COMPANY, N.A | 0.00% | 0.09% | 2,020 | 2,020 | 100.00% | 138,350 | Jun 30, 2024 |
| CLEAR STREET MARKETS LLC | 0.00% | 0.01% | 816 | 816 | 100.00% | 56,000 | Jun 30, 2024 |
| CLEARSTEAD ADVISORS, LLC | 0.00% | 0.00% | 698 | 698 | 100.00% | 47,807 | Jun 30, 2024 |
| MANCHESTER CAPITAL MANAGEMENT LLC | 0.00% | 0.00% | 434 | 434 | 100.00% | 29,725 | Jun 30, 2024 |
| 0.00% | 0.00% | 120 | 120 | 100.00% | 8,219 | Jun 30, 2024 | |
| PICTON MAHONEY ASSET MANAGEMENT | 0.00% | 0.00% | 120 | 120 | 100.00% | 8,000 | Jun 30, 2024 |
| BESSEMER GROUP INC | 0.00% | - | 115 | 115 | 100.00% | 8,000 | Jun 30, 2024 |
| SMARTLEAF ASSET MANAGEMENT LLC | 0.00% | 0.00% | 101 | 101 | 100.00% | 7,168 | Jun 30, 2024 |
| NBC SECURITIES, INC. | 0.00% | 0.00% | 96 | 96 | 100.00% | 6,000 | Jun 30, 2024 |
| ITAU UNIBANCO HOLDING S.A. | 0.00% | 0.00% | 50 | 50 | 100.00% | 3,425 | Jun 30, 2024 |
| COHEN & STEERS, INC. | - | - | 42 | 42 | 100.00% | 3,000 | Jun 30, 2024 |
| INNEALTA CAPITAL, LLC | - | 0.00% | 36 | 36 | 100.00% | 2,466 | Jun 30, 2024 |
| RONALD BLUE TRUST, INC. | - | - | 33 | 33 | 100.00% | 2,284 | Jun 30, 2024 |
| STEPHENS CONSULTING, LLC | - | 0.00% | 32 | 32 | 100.00% | 2,192 | Jun 30, 2024 |
| JOHNSON FINANCIAL GROUP, INC. | - | 0.00% | 17 | 17 | 100.00% | 1,165 | Jun 30, 2024 |
Intra-Cellular Therapies's largest new institutional shareholder by number of shares is NORGES BANK, purchased 1.94M shares, valued at $133.13M, as of undefined.
Institutional Sold Out
| Name | % Total Shares | % Total Assets | Current Shares | Change Amount | Change % | Market Value | Date |
|---|---|---|---|---|---|---|---|
| AVIDITY PARTNERS MANAGEMENT LP | - | - | - | -600,000 | -100.00% | - | Jun 30, 2024 |
| FARALLON CAPITAL MANAGEMENT LLC | - | - | - | -231,000 | -100.00% | - | Jun 30, 2024 |
| DEEP TRACK CAPITAL, LP | - | - | - | -175,400 | -100.00% | - | Jun 30, 2024 |
| GREAT POINT PARTNERS LLC | - | - | - | -150,000 | -100.00% | - | Jun 30, 2024 |
| GREAT LAKES ADVISORS, LLC | - | - | - | -148,815 | -100.00% | - | Jun 30, 2024 |
| VERITION FUND MANAGEMENT LLC | - | - | - | -110,000 | -100.00% | - | Jun 30, 2024 |
| BANK OF AMERICA CORP /DE/ | - | - | - | -75,000 | -100.00% | - | Jun 30, 2024 |
| HAP TRADING, LLC | - | - | - | -68,011 | -100.00% | - | Jun 30, 2024 |
| TIG ADVISORS, LLC | - | - | - | -50,500 | -100.00% | - | Jun 30, 2024 |
| GHOST TREE CAPITAL, LLC | - | - | - | -50,000 | -100.00% | - | Jun 30, 2024 |
| AFFINITY ASSET ADVISORS, LLC | - | - | - | -50,000 | -100.00% | - | Jun 30, 2024 |
| AMERICAN INTERNATIONAL GROUP, INC. | - | - | - | -46,180 | -100.00% | - | Jun 30, 2024 |
| PANAGORA ASSET MANAGEMENT INC | - | - | - | -37,179 | -100.00% | - | Jun 30, 2024 |
| PEAK6 INVESTMENTS LLC | - | - | - | -33,900 | -100.00% | - | Jun 30, 2024 |
| CIBC WORLD MARKETS CORP | - | - | - | -25,000 | -100.00% | - | Jun 30, 2024 |
| CINCTIVE CAPITAL MANAGEMENT LP | - | - | - | -23,100 | -100.00% | - | Jun 30, 2024 |
| COOKSON PEIRCE & CO INC | - | - | - | -22,383 | -100.00% | - | Jun 30, 2024 |
| EXOME ASSET MANAGEMENT LLC | - | - | - | -20,300 | -100.00% | - | Jun 30, 2024 |
| SQUAREPOINT OPS LLC | - | - | - | -20,000 | -100.00% | - | Jun 30, 2024 |
| EDGESTREAM PARTNERS, L.P. | - | - | - | -18,137 | -100.00% | - | Jun 30, 2024 |
| BAILARD, INC. | - | - | - | -15,480 | -100.00% | - | Jun 30, 2024 |
| ACUTA CAPITAL PARTNERS, LLC | - | - | - | -13,300 | -100.00% | - | Jun 30, 2024 |
| AMERITAS INVESTMENT PARTNERS, INC. | - | - | - | -9,484 | -100.00% | - | Jun 30, 2024 |
| JENNISON ASSOCIATES LLC | - | - | - | -9,212 | -100.00% | - | Jun 30, 2024 |
| WOLVERINE TRADING, LLC | - | - | - | -6,700 | -100.00% | - | Jun 30, 2024 |
| BOOTHBAY FUND MANAGEMENT, LLC | - | - | - | -5,700 | -100.00% | - | Jun 30, 2024 |
| TWO SIGMA INVESTMENTS, LP | - | - | - | -5,000 | -100.00% | - | Jun 30, 2024 |
| RAYMOND JAMES FINANCIAL SERVICES ADVISORS, INC. | - | - | - | -4,981 | -100.00% | - | Jun 30, 2024 |
| METROPOLITAN LIFE INSURANCE CO/NY | - | - | - | -4,921 | -100.00% | - | Jun 30, 2024 |
| PRELUDE CAPITAL MANAGEMENT, LLC | - | - | - | -4,700 | -100.00% | - | Jun 30, 2024 |
| GTS SECURITIES LLC | - | - | - | -4,200 | -100.00% | - | Jun 30, 2024 |
| ALPINE WOODS CAPITAL INVESTORS, LLC | - | - | - | -4,000 | -100.00% | - | Jun 30, 2024 |
| GEMMER ASSET MANAGEMENT LLC | - | - | - | -4,000 | -100.00% | - | Jun 30, 2024 |
| VIDENT ADVISORY, LLC | - | - | - | -3,772 | -100.00% | - | Jun 30, 2024 |
| MAVERICK CAPITAL LTD | - | - | - | -3,660 | -100.00% | - | Jun 30, 2024 |
| KAPITALO INVESTIMENTOS LTDA | - | - | - | -3,549 | -100.00% | - | Jun 30, 2024 |
| HIGHTOWER ADVISORS, LLC | - | - | - | -3,474 | -100.00% | - | Jun 30, 2024 |
| WORTH VENTURE PARTNERS, LLC | - | - | - | -3,300 | -100.00% | - | Jun 30, 2024 |
| LEVEL FOUR ADVISORY SERVICES, LLC | - | - | - | -3,076 | -100.00% | - | Jun 30, 2024 |
| PINNACLE WEALTH PLANNING SERVICES, INC. | - | - | - | -2,956 | -100.00% | - | Jun 30, 2024 |
| BEACON POINTE ADVISORS, LLC | - | - | - | -2,911 | -100.00% | - | Jun 30, 2024 |
| BANQUE CANTONALE VAUDOISE | - | - | - | -776 | -100.00% | - | Jun 30, 2024 |
| FIDELIS CAPITAL PARTNERS, LLC | - | - | - | -762 | -100.00% | - | Jun 30, 2024 |
| AQUATIC CAPITAL MANAGEMENT LLC | - | - | - | -300 | -100.00% | - | Jun 30, 2024 |
| TRUVESTMENTS CAPITAL LLC | - | - | - | -89 | -100.00% | - | Jun 30, 2024 |
| BENJAMIN F. EDWARDS & COMPANY, INC. | - | - | - | -84 | -100.00% | - | Jun 30, 2024 |
| CREEKMUR ASSET MANAGEMENT LLC | - | - | - | -50 | -100.00% | - | Jun 30, 2024 |
| IFP ADVISORS, INC | - | - | - | -17 | -100.00% | - | Jun 30, 2024 |
| CONTINUUM ADVISORY, LLC | - | - | - | -6 | -100.00% | - | Jun 30, 2024 |
| FINANCIAL SYNERGIES WEALTH ADVISORS, INC. | - | - | - | -6 | -100.00% | - | Jun 30, 2024 |
| SANCTUARY WEALTH MANAGEMENT, L.L.C. | - | - | - | -1 | -100.00% | - | Jun 30, 2024 |
| FINANCIAL GRAVITY ASSET MANAGEMENT, INC. | - | - | - | -1 | -100.00% | - | Jun 30, 2024 |
Intra-Cellular Therapies's largest sold out institutional shareholder by shares sold is AVIDITY PARTNERS MANAGEMENT LP, sold -0.60M shares, valued at -, as of undefined.
Intra-Cellular Therapies Mutual Fund Holders
| Name | % Total Assets | Total Shares | Change Amount | Change % | Date |
|---|---|---|---|---|---|
| Manager Directed Portfolios | 2.32% | 379,486 | - | - | Jan 31, 2024 |
| SPARROW FUNDS | 0.99% | 3,525 | - | - | Feb 29, 2024 |
| HARTFORD HLS SERIES FUND II INC | 0.42% | 103,933 | - | - | Dec 31, 2023 |
| LORD ABBETT DEVELOPING GROWTH FUND, INC. | 0.39% | 366,261 | -71,915 | -16.41% | Jan 31, 2024 |
| WASATCH FUNDS TRUST | 0.24% | 2,219,875 | 98,446 | 4.64% | Mar 31, 2024 |
| Cushing Mutual Funds Trust | 0.19% | 5,623 | - | - | Aug 31, 2023 |
| GENERAL AMERICAN INVESTORS CO INC | 0.19% | 260,439 | - | - | Mar 31, 2024 |
| AB DISCOVERY GROWTH FUND, INC. | 0.18% | 274,768 | -37,049 | -11.88% | Jan 31, 2024 |
| T. Rowe Price Quantitative Management Funds, Inc. | 0.16% | 520,052 | 5,717 | 1.11% | Mar 31, 2024 |
| FIDELITY MT VERNON STREET TRUST | 0.16% | 4,645,672 | -121,578 | -2.55% | Feb 29, 2024 |
| VANGUARD VALLEY FORGE FUNDS | 0.12% | 60,697 | - | - | Mar 31, 2024 |
| TEKLA LIFE SCIENCES INVESTORS | 0.11% | 53,000 | 13,525 | 34.26% | Mar 31, 2024 |
| DELAWARE GROUP EQUITY FUNDS IV | 0.10% | 117,573 | -1,544 | -1.30% | Mar 28, 2024 |
| TEKLA HEALTHCARE INVESTORS | 0.09% | 80,822 | 61,602 | 320.51% | Mar 31, 2024 |
| FRANKLIN STRATEGIC SERIES | 0.09% | 771,762 | -9,854 | -1.26% | Jan 31, 2024 |
| LORD ABBETT RESEARCH FUND INC | 0.09% | 87,707 | - | - | Feb 29, 2024 |
| VANGUARD EXPLORER FUND | 0.08% | 954,330 | 210,744 | 28.34% | Jan 31, 2024 |
| Tema ETF Trust | 0.08% | 3,388 | 3,388 | - | Feb 29, 2024 |
| T. Rowe Price Health Sciences Fund, Inc. | 0.07% | 244,964 | - | - | Mar 31, 2024 |
| T. Rowe Price New Horizons Fund, Inc. | 0.07% | 364,278 | -35,625 | -8.91% | Mar 31, 2024 |
| FIRST TRUST EXCHANGE-TRADED FUND | 0.06% | 582,422 | 582,231 | 304832.98% | Mar 31, 2024 |
| PRUDENTIAL SECTOR FUNDS, INC. | 0.05% | 104,098 | - | - | Feb 29, 2024 |
| AMERICAN CENTURY MUTUAL FUNDS, INC. | 0.04% | 452,973 | 43,112 | 10.52% | Jan 31, 2024 |
| VICTORY VARIABLE INSURANCE FUNDS | 0.04% | 21,540 | - | - | Mar 31, 2024 |
| Humankind Benefit Corp | 0.04% | 862 | -16 | -1.82% | Dec 31, 2023 |
| Voya VARIABLE PRODUCTS TRUST | 0.04% | 13,780 | -659 | -4.56% | Mar 31, 2024 |
| Voya EQUITY TRUST | 0.04% | 53,508 | 3,381 | 6.74% | Feb 29, 2024 |
| WANGER ADVISORS TRUST | 0.04% | 19,444 | 19,444 | - | Mar 31, 2024 |
| COLUMBIA ACORN TRUST | 0.03% | 102,376 | 102,376 | - | Mar 31, 2024 |
| QUANTITATIVE MASTER SERIES LLC | 0.03% | 165,430 | -5,187 | -3.04% | Mar 31, 2024 |
| DEUTSCHE DWS INVESTMENTS VIT FUNDS | 0.02% | 13,977 | -305 | -2.14% | Mar 31, 2024 |
| FIRST TRUST EXCHANGE-TRADED ALPHADEX FUND | 0.02% | 76,014 | 66,639 | 710.82% | Jan 31, 2024 |
| LEGG MASON PARTNERS VARIABLE EQUITY TRUST | 0.02% | 75,648 | 3,000 | 4.13% | Dec 29, 2023 |
| VANGUARD INDEX FUNDS | 0.02% | 7,922,822 | -1,266,070 | -13.78% | Mar 31, 2024 |
| FIDELITY DESTINY PORTFOLIOS | 0.02% | 39,900 | - | - | Mar 31, 2024 |
| ALGER FUNDS | 0.02% | 16,740 | -48,845 | -74.48% | Jan 31, 2024 |
| AIM GROWTH SERIES (INVESCO GROWTH SERIES) | 0.02% | 529,491 | 12,340 | 2.39% | Mar 31, 2024 |
| LEGG MASON PARTNERS INVESTMENT TRUST | 0.02% | 805,724 | 42,240 | 5.53% | Jan 31, 2024 |
| DELAWARE GROUP EQUITY FUNDS V | 0.02% | 921,771 | -63,529 | -6.45% | Feb 29, 2024 |
| AB CAP FUND, INC. | 0.02% | 530,931 | -87,718 | -14.18% | Jan 31, 2024 |
| FIDELITY CONTRAFUND | 0.01% | 941,088 | 196,268 | 26.35% | Mar 31, 2024 |
| DEUTSCHE DWS INVESTMENT TRUST | 0.01% | 42,700 | - | - | Mar 31, 2024 |
| PRUDENTIAL JENNISON BLEND FUND, INC. | 0.01% | 8,381 | -6,484 | -43.62% | Feb 29, 2024 |
| FIDELITY ADVISOR SERIES VII | 0.01% | 110,600 | 6,300 | 6.04% | Jan 31, 2024 |
| VANGUARD SPECIALIZED FUNDS | 0.01% | 701,710 | - | - | Jan 31, 2024 |
| AIM FUNDS GROUP (INVESCO FUNDS GROUP) | 0.01% | 64,929 | 64,929 | - | Mar 31, 2024 |
| Collaborative Investment Series Trust | 0.01% | 1,960 | - | - | Mar 31, 2024 |
| FIDELITY SECURITIES FUND | 0.01% | 1,131,175 | 395,500 | 53.76% | Jan 31, 2024 |
| FIDELITY CAPITAL TRUST | 0.01% | 135,300 | -31,031 | -18.66% | Jan 31, 2024 |
| SARATOGA ADVANTAGE TRUST | 0.01% | 729 | - | - | Feb 29, 2024 |
| TIAA SEPARATE ACCOUNT VA 1 | 0.01% | 2,522 | - | - | Mar 31, 2024 |
| AMG FUNDS | 0.01% | 291,802 | -15,442 | -5.03% | Mar 28, 2024 |
| VARIABLE INSURANCE PRODUCTS FUND II | 0.01% | 111,914 | 19,868 | 21.58% | Mar 31, 2024 |
| DRIEHAUS MUTUAL FUNDS | 0.01% | 80,888 | - | - | Mar 28, 2024 |
| ROYCE VALUE TRUST, INC. | 0.01% | 7,000 | 7,000 | - | Mar 31, 2024 |
| FIDELITY COMMONWEALTH TRUST | 0.01% | 25,063 | 403 | 1.63% | Feb 29, 2024 |
| JNL VARIABLE FUND LLC | 0.01% | 43,841 | 9,051 | 26.02% | Mar 31, 2020 |
| Bernstein Fund Inc | 0.01% | 63,930 | -3,570 | -5.29% | Mar 31, 2024 |
| John Hancock Exchange-Traded Fund Trust | 0.01% | 44,718 | -235 | -0.52% | Jan 31, 2024 |
| T. Rowe Price Equity Series, Inc. | 0.01% | 10,976 | - | - | Mar 31, 2024 |
| SEI Catholic Values Trust | 0.01% | 17,462 | - | - | Feb 29, 2024 |
| SCHWAB CAPITAL TRUST | 0.01% | 257,253 | 852 | 0.33% | Jan 31, 2024 |
| Zacks Trust | 0.01% | 542 | - | - | Feb 29, 2024 |
| RYDEX SERIES FUNDS | 0.01% | 21,825 | 20,974 | 2464.63% | Dec 31, 2023 |
| LORD ABBETT SECURITIES TRUST | 0.00% | 22,293 | -6,509 | -22.60% | Jan 31, 2024 |
| IndexIQ ETF Trust | 0.00% | 10,410 | 10,410 | - | Jan 31, 2024 |
| HUSSMAN INVESTMENT TRUST | 0.00% | 15,500 | - | - | Dec 31, 2023 |
| Principal Exchange-Traded Funds | 0.00% | 50,580 | 39,176 | 343.53% | Mar 31, 2024 |
| FIDELITY CONCORD STREET TRUST | 0.00% | 847,868 | 31,294 | 3.83% | Feb 29, 2024 |
| NEUBERGER BERMAN EQUITY FUNDS | 0.00% | 37,682 | 37,682 | - | Feb 29, 2024 |
| Calvert Variable Products, Inc. | 0.00% | 9,484 | - | - | Mar 31, 2024 |
| ETFis Series Trust I | 0.00% | 4,994 | 271 | 5.74% | Jan 31, 2024 |
| HARTFORD SERIES FUND INC | 0.00% | 146,344 | 73,066 | 99.71% | Mar 31, 2024 |
| Federated Hermes MDT Series | 0.00% | 7,817 | - | - | Jan 31, 2024 |
| Goldman Sachs ETF Trust II | 0.00% | 3,149 | 9 | 0.29% | Feb 29, 2024 |
| UBS FUNDS | 0.00% | 14,125 | -374 | -2.58% | Mar 31, 2024 |
| DEUTSCHE DWS VARIABLE SERIES II | 0.00% | 7,000 | - | - | Mar 31, 2024 |
| AMG Funds IV | 0.00% | 8,412 | -225 | -2.61% | Jan 31, 2024 |
| Fidelity Commonwealth Trust II | 0.00% | 18,480 | - | - | Aug 31, 2023 |
| RYDEX VARIABLE TRUST | 0.00% | 3,004 | 2,948 | 5264.29% | Dec 31, 2023 |
| VARIABLE INSURANCE PRODUCTS FUND III | 0.00% | 20,380 | - | - | Mar 31, 2024 |
| GOLDMAN SACHS VARIABLE INSURANCE TRUST | 0.00% | 10,254 | 3,517 | 52.20% | Mar 31, 2024 |
| North Square Investments Trust | 0.00% | 23,640 | 17,817 | 305.98% | Feb 29, 2024 |
| Guardian Variable Products Trust | 0.00% | 39,471 | -2,200 | -5.28% | Mar 31, 2024 |
| ROYCE FUND | 0.00% | 15,500 | 15,500 | - | Mar 31, 2024 |
| STEWARD FUNDS, INC. | 0.00% | 5,500 | -2,110 | -27.73% | Jan 31, 2024 |
| HARBOR FUNDS | 0.00% | 48,789 | - | - | Jan 31, 2024 |
| FINANCIAL INVESTORS TRUST | 0.00% | 164,830 | 839 | 0.51% | Jan 31, 2024 |
| TIAA-CREF LIFE FUNDS | 0.00% | 5,584 | 1,014 | 22.19% | Mar 31, 2024 |
| MASSMUTUAL PREMIER FUNDS | 0.00% | 56,064 | 1,033 | 1.88% | Dec 31, 2023 |
| Mutual of America Variable Insurance Portfolios, Inc. | 0.00% | 1,395 | 226 | 19.33% | Sep 30, 2023 |
| VANGUARD INSTITUTIONAL INDEX FUNDS | 0.00% | 57,474 | -4,425 | -7.15% | Mar 31, 2024 |
| FORUM FUNDS | 0.00% | 4,090 | -20 | -0.49% | Mar 31, 2024 |
| AB VARIABLE PRODUCTS SERIES FUND, INC. | 0.00% | 7,751 | -1,289 | -14.26% | Mar 31, 2024 |
| INVESCO EXCHANGE-TRADED FUND TRUST | 0.00% | 139,792 | 15,047 | 12.06% | Jan 31, 2024 |
| OPTIMUM FUND TRUST | 0.00% | 72,956 | - | - | Mar 28, 2024 |
| CARILLON SERIES TRUST | 0.00% | 92,135 | -34,006 | -26.96% | Mar 31, 2024 |
| BNY Mellon Strategic Funds, Inc. | 0.00% | 3,617 | -174 | -4.59% | Feb 29, 2024 |
| Innovator ETFs Trust | 0.00% | 6,566 | -22,716 | -77.58% | Jan 31, 2024 |
| DELAWARE VIP TRUST | 0.00% | 5,671 | -139 | -2.39% | Mar 28, 2024 |
Intra-Cellular Therapies's largest mutual fund holder by % of total assets is "Manager Directed Portfolios", owning 379.49K shares, compromising 2.32% of its total assets.
Intra-Cellular Therapies Institutional Ownership Trends
Institutional Holdings Trend
| Date | Holdings | Change % |
|---|---|---|
| 30 Jun, 24 | 138 | -62.40% |
| 31 Mar, 24 | 367 | 5.46% |
| 31 Dec, 23 | 348 | 16.00% |
| 30 Sep, 23 | 300 | 2.04% |
| 30 Jun, 23 | 294 | 2.44% |
| 31 Mar, 23 | 287 | -1.71% |
| 31 Dec, 22 | 292 | 4.66% |
| 30 Sep, 22 | 279 | 2.95% |
| 30 Jun, 22 | 271 | 6.69% |
| 31 Mar, 22 | 254 | 12.39% |
| 31 Dec, 21 | 226 | 17.71% |
| 30 Sep, 21 | 192 | -2.54% |
| 30 Jun, 21 | 197 | 9.44% |
| 31 Mar, 21 | 180 | -8.16% |
| 31 Dec, 20 | 196 | 0.51% |
| 30 Sep, 20 | 195 | 8.94% |
| 30 Jun, 20 | 179 | 16.23% |
| 31 Mar, 20 | 154 | -10.47% |
| 31 Dec, 19 | 172 | 12.42% |
| 30 Sep, 19 | 153 | -2.55% |
| 30 Jun, 19 | 157 | 6.80% |
| 31 Mar, 19 | 147 | - |
| 31 Dec, 18 | 147 | -1.34% |
| 30 Sep, 18 | 149 | 0.68% |
| 30 Jun, 18 | 148 | 2.78% |
| 31 Mar, 18 | 144 | -0.69% |
| 31 Dec, 17 | 145 | -7.64% |
| 30 Sep, 17 | 157 | 45.37% |
| 30 Jun, 17 | 108 | -14.96% |
| 31 Mar, 17 | 127 | -6.62% |
| 31 Dec, 16 | 136 | -11.11% |
| 30 Sep, 16 | 153 | 3.38% |
| 30 Jun, 16 | 148 | 12.98% |
| 31 Mar, 16 | 131 | -5.76% |
| 31 Dec, 15 | 139 | 0.72% |
| 30 Sep, 15 | 138 | 45.26% |
| 30 Jun, 15 | 95 | 28.38% |
| 31 Mar, 15 | 74 | 57.45% |
| 31 Dec, 14 | 47 | -2.08% |
| 30 Sep, 14 | 48 | -12.73% |
| 30 Jun, 14 | 55 | 57.14% |
| 31 Mar, 14 | 35 | - |
As of 30 Jun 24, 138 institutions are holding Intra-Cellular Therapies's shares, representing a decrease of -62.40% compared to the previous quarter.
Shares Outstanding Trend
| Date | Shares Outstanding | Change % |
|---|---|---|
| 30 Jun, 24 | 10,156,897 | -88.33% |
| 31 Mar, 24 | 87,032,607 | -2.57% |
| 31 Dec, 23 | 89,328,526 | 3.75% |
| 30 Sep, 23 | 86,096,976 | 3.28% |
| 30 Jun, 23 | 83,364,107 | -0.31% |
| 31 Mar, 23 | 83,627,273 | 0.64% |
| 31 Dec, 22 | 83,093,843 | -0.14% |
| 30 Sep, 22 | 83,213,484 | 2.47% |
| 30 Jun, 22 | 81,208,190 | 0.84% |
| 31 Mar, 22 | 80,532,005 | 17.16% |
| 31 Dec, 21 | 68,733,870 | 0.66% |
| 30 Sep, 21 | 68,285,167 | 1.92% |
| 30 Jun, 21 | 66,996,861 | -1.47% |
| 31 Mar, 21 | 67,999,372 | 1.31% |
| 31 Dec, 20 | 67,122,234 | 5.27% |
| 30 Sep, 20 | 63,760,726 | 30.78% |
| 30 Jun, 20 | 48,755,734 | 1.47% |
| 31 Mar, 20 | 48,047,585 | 26.33% |
| 31 Dec, 19 | 38,034,466 | -4.50% |
| 30 Sep, 19 | 39,827,002 | 3.80% |
| 30 Jun, 19 | 38,368,604 | -0.18% |
| 31 Mar, 19 | 38,438,691 | 1.38% |
| 31 Dec, 18 | 37,914,117 | -0.48% |
| 30 Sep, 18 | 38,097,272 | -3.30% |
| 30 Jun, 18 | 39,398,781 | -0.01% |
| 31 Mar, 18 | 39,402,898 | 3.02% |
| 31 Dec, 17 | 38,248,768 | -6.32% |
| 30 Sep, 17 | 40,828,161 | 31.83% |
| 30 Jun, 17 | 30,969,159 | 5.63% |
| 31 Mar, 17 | 29,319,174 | -2.70% |
| 31 Dec, 16 | 30,132,835 | 8.03% |
| 30 Sep, 16 | 27,893,424 | -8.66% |
| 30 Jun, 16 | 30,536,354 | 3.78% |
| 31 Mar, 16 | 29,425,164 | 3.15% |
| 31 Dec, 15 | 28,527,266 | 2.37% |
| 30 Sep, 15 | 27,866,465 | 54.18% |
| 30 Jun, 15 | 18,074,474 | 6.60% |
| 31 Mar, 15 | 16,955,528 | 38.80% |
| 31 Dec, 14 | 12,215,761 | 0.99% |
| 30 Sep, 14 | 12,095,832 | 0.07% |
| 30 Jun, 14 | 12,087,115 | 9.50% |
| 31 Mar, 14 | 11,038,114 | - |
Intra-Cellular Therapies (ITCI) has 10.16M shares outstanding as of 30 Jun 24, down -88.33% compared to the previous quarter.
Institutional Ownership Trend
| Date | Ownership % | Change % |
|---|---|---|
| 30 Jun, 24 | 10.48% | 0.13% |
| 31 Mar, 24 | 90.77% | 1.05% |
| 31 Dec, 23 | 92.91% | 1.15% |
| 30 Sep, 23 | 89.73% | 1.17% |
| 30 Jun, 23 | 87.63% | 1.13% |
| 31 Mar, 23 | 87.90% | 1.14% |
| 31 Dec, 22 | 87.70% | 1.13% |
| 30 Sep, 22 | 88.04% | 1.19% |
| 30 Jun, 22 | 86.13% | 1.14% |
| 31 Mar, 22 | 86.96% | 1.22% |
| 31 Dec, 21 | 84.59% | 1.20% |
| 30 Sep, 21 | 83.94% | 1.23% |
| 30 Jun, 21 | 82.48% | 1.17% |
| 31 Mar, 21 | 84.01% | 0.92% |
| 31 Dec, 20 | 95.39% | 1.13% |
| 30 Sep, 20 | 91.70% | 1.70% |
| 30 Jun, 20 | 73.39% | 1.35% |
| 31 Mar, 20 | 73.80% | 1.55% |
| 31 Dec, 19 | 68.92% | 1.32% |
| 30 Sep, 19 | 72.14% | 1.49% |
| 30 Jun, 19 | 69.58% | 1.43% |
| 31 Mar, 19 | 69.74% | 1.45% |
| 31 Dec, 18 | 69.30% | 1.43% |
| 30 Sep, 18 | 69.64% | 1.34% |
| 30 Jun, 18 | 72.03% | 1.39% |
| 31 Mar, 18 | 72.07% | 1.05% |
| 31 Dec, 17 | 82.82% | 0.94% |
| 30 Sep, 17 | 94.02% | 1.85% |
| 30 Jun, 17 | 71.33% | 1.56% |
| 31 Mar, 17 | 67.58% | 1.39% |
| 31 Dec, 16 | 69.69% | 1.68% |
| 30 Sep, 16 | 64.49% | 1.29% |
| 30 Jun, 16 | 70.62% | 1.52% |
| 31 Mar, 16 | 68.12% | 1.09% |
| 31 Dec, 15 | 79.09% | 1.27% |
| 30 Sep, 15 | 78.90% | 2.96% |
| 30 Jun, 15 | 51.64% | 1.70% |
| 31 Mar, 15 | 55.09% | 3.03% |
| 31 Dec, 14 | 42.64% | 2.52% |
| 30 Sep, 14 | 41.17% | 2.41% |
| 30 Jun, 14 | 41.29% | 2.38% |
| 31 Mar, 14 | 41.69% | - |
As of 30 Jun 24, Intra-Cellular Therapies is held by 10.48% institutional shareholders, representing a 0.13% growth compared to 31 Mar 24.
Institutional Increased Positions Trend
| Date | Increased Positions | Change % |
|---|---|---|
| 30 Jun, 24 | 74 | -58.19% |
| 31 Mar, 24 | 177 | -3.28% |
| 31 Dec, 23 | 183 | 12.96% |
| 30 Sep, 23 | 162 | -1.82% |
| 30 Jun, 23 | 165 | 11.49% |
| 31 Mar, 23 | 148 | 1.37% |
| 31 Dec, 22 | 146 | 1.39% |
| 30 Sep, 22 | 144 | 4.35% |
| 30 Jun, 22 | 138 | -11.54% |
| 31 Mar, 22 | 156 | 40.54% |
| 31 Dec, 21 | 111 | 19.35% |
| 30 Sep, 21 | 93 | -2.11% |
| 30 Jun, 21 | 95 | 33.80% |
| 31 Mar, 21 | 71 | -27.55% |
| 31 Dec, 20 | 98 | -13.27% |
| 30 Sep, 20 | 113 | 17.71% |
| 30 Jun, 20 | 96 | 2.13% |
| 31 Mar, 20 | 94 | 22.08% |
| 31 Dec, 19 | 77 | 4.05% |
| 30 Sep, 19 | 74 | 12.12% |
| 30 Jun, 19 | 66 | -4.35% |
| 31 Mar, 19 | 69 | 18.97% |
| 31 Dec, 18 | 58 | 7.41% |
| 30 Sep, 18 | 54 | -20.59% |
| 30 Jun, 18 | 68 | 6.25% |
| 31 Mar, 18 | 64 | -12.33% |
| 31 Dec, 17 | 73 | -20.65% |
| 30 Sep, 17 | 92 | 104.44% |
| 30 Jun, 17 | 45 | -8.16% |
| 31 Mar, 17 | 49 | -37.97% |
| 31 Dec, 16 | 79 | 19.70% |
| 30 Sep, 16 | 66 | -25.84% |
| 30 Jun, 16 | 89 | 12.66% |
| 31 Mar, 16 | 79 | 5.33% |
| 31 Dec, 15 | 75 | -16.67% |
| 30 Sep, 15 | 90 | 40.63% |
| 30 Jun, 15 | 64 | 18.52% |
| 31 Mar, 15 | 54 | 157.14% |
| 31 Dec, 14 | 21 | -16.00% |
| 30 Sep, 14 | 25 | -44.44% |
| 30 Jun, 14 | 45 | 28.57% |
| 31 Mar, 14 | 35 | - |
74 institutional shareholders have increased their position in ITCI stock as of 30 Jun 24 compared to 177 in the previous quarter (a -58.19% decrease).
Institutional Reduced Positions Trend
| Date | Reduced Positions | Change % |
|---|---|---|
| 30 Jun, 24 | 48 | -62.20% |
| 31 Mar, 24 | 127 | 11.40% |
| 31 Dec, 23 | 114 | 26.67% |
| 30 Sep, 23 | 90 | 12.50% |
| 30 Jun, 23 | 80 | -10.11% |
| 31 Mar, 23 | 89 | -4.30% |
| 31 Dec, 22 | 93 | 6.90% |
| 30 Sep, 22 | 87 | -2.25% |
| 30 Jun, 22 | 89 | 36.92% |
| 31 Mar, 22 | 65 | - |
| 31 Dec, 21 | 65 | 22.64% |
| 30 Sep, 21 | 53 | -17.19% |
| 30 Jun, 21 | 64 | -5.88% |
| 31 Mar, 21 | 68 | 23.64% |
| 31 Dec, 20 | 55 | 27.91% |
| 30 Sep, 20 | 43 | 30.30% |
| 30 Jun, 20 | 33 | 10.00% |
| 31 Mar, 20 | 30 | -34.78% |
| 31 Dec, 19 | 46 | 21.05% |
| 30 Sep, 19 | 38 | -2.56% |
| 30 Jun, 19 | 39 | 34.48% |
| 31 Mar, 19 | 29 | -40.82% |
| 31 Dec, 18 | 49 | 6.52% |
| 30 Sep, 18 | 46 | 6.98% |
| 30 Jun, 18 | 43 | -8.51% |
| 31 Mar, 18 | 47 | 34.29% |
| 31 Dec, 17 | 35 | 45.83% |
| 30 Sep, 17 | 24 | -25.00% |
| 30 Jun, 17 | 32 | -15.79% |
| 31 Mar, 17 | 38 | 40.74% |
| 31 Dec, 16 | 27 | -35.71% |
| 30 Sep, 16 | 42 | 50.00% |
| 30 Jun, 16 | 28 | -15.15% |
| 31 Mar, 16 | 33 | -19.51% |
| 31 Dec, 15 | 41 | 24.24% |
| 30 Sep, 15 | 33 | 94.12% |
| 30 Jun, 15 | 17 | 54.55% |
| 31 Mar, 15 | 11 | -35.29% |
| 31 Dec, 14 | 17 | 21.43% |
| 30 Sep, 14 | 14 | 100.00% |
| 30 Jun, 14 | 7 | - |
| 31 Mar, 14 | - | - |
48 institutional shareholders have reduced their position in ITCI stock as of 30 Jun 24 compared to 127 in the previous quarter (a -62.20% decrease).
All Institutional Ownership Trend Data
| Date | Holdings | Change % | Shares Outstanding | Change % | Ownership % | Change % | Increased Positions | Change % | Reduced Positions | Change % |
|---|---|---|---|---|---|---|---|---|---|---|
| 30 Jun, 24 | 138 | -62.40% | 10,156,897 | -88.33% | 10.48% | 0.13% | 74 | -58.19% | 48 | -62.20% |
| 31 Mar, 24 | 367 | 5.46% | 87,032,607 | -2.57% | 90.77% | 1.05% | 177 | -3.28% | 127 | 11.40% |
| 31 Dec, 23 | 348 | 16.00% | 89,328,526 | 3.75% | 92.91% | 1.15% | 183 | 12.96% | 114 | 26.67% |
| 30 Sep, 23 | 300 | 2.04% | 86,096,976 | 3.28% | 89.73% | 1.17% | 162 | -1.82% | 90 | 12.50% |
| 30 Jun, 23 | 294 | 2.44% | 83,364,107 | -0.31% | 87.63% | 1.13% | 165 | 11.49% | 80 | -10.11% |
| 31 Mar, 23 | 287 | -1.71% | 83,627,273 | 0.64% | 87.90% | 1.14% | 148 | 1.37% | 89 | -4.30% |
| 31 Dec, 22 | 292 | 4.66% | 83,093,843 | -0.14% | 87.70% | 1.13% | 146 | 1.39% | 93 | 6.90% |
| 30 Sep, 22 | 279 | 2.95% | 83,213,484 | 2.47% | 88.04% | 1.19% | 144 | 4.35% | 87 | -2.25% |
| 30 Jun, 22 | 271 | 6.69% | 81,208,190 | 0.84% | 86.13% | 1.14% | 138 | -11.54% | 89 | 36.92% |
| 31 Mar, 22 | 254 | 12.39% | 80,532,005 | 17.16% | 86.96% | 1.22% | 156 | 40.54% | 65 | - |
| 31 Dec, 21 | 226 | 17.71% | 68,733,870 | 0.66% | 84.59% | 1.20% | 111 | 19.35% | 65 | 22.64% |
| 30 Sep, 21 | 192 | -2.54% | 68,285,167 | 1.92% | 83.94% | 1.23% | 93 | -2.11% | 53 | -17.19% |
| 30 Jun, 21 | 197 | 9.44% | 66,996,861 | -1.47% | 82.48% | 1.17% | 95 | 33.80% | 64 | -5.88% |
| 31 Mar, 21 | 180 | -8.16% | 67,999,372 | 1.31% | 84.01% | 0.92% | 71 | -27.55% | 68 | 23.64% |
| 31 Dec, 20 | 196 | 0.51% | 67,122,234 | 5.27% | 95.39% | 1.13% | 98 | -13.27% | 55 | 27.91% |
| 30 Sep, 20 | 195 | 8.94% | 63,760,726 | 30.78% | 91.70% | 1.70% | 113 | 17.71% | 43 | 30.30% |
| 30 Jun, 20 | 179 | 16.23% | 48,755,734 | 1.47% | 73.39% | 1.35% | 96 | 2.13% | 33 | 10.00% |
| 31 Mar, 20 | 154 | -10.47% | 48,047,585 | 26.33% | 73.80% | 1.55% | 94 | 22.08% | 30 | -34.78% |
| 31 Dec, 19 | 172 | 12.42% | 38,034,466 | -4.50% | 68.92% | 1.32% | 77 | 4.05% | 46 | 21.05% |
| 30 Sep, 19 | 153 | -2.55% | 39,827,002 | 3.80% | 72.14% | 1.49% | 74 | 12.12% | 38 | -2.56% |
| 30 Jun, 19 | 157 | 6.80% | 38,368,604 | -0.18% | 69.58% | 1.43% | 66 | -4.35% | 39 | 34.48% |
| 31 Mar, 19 | 147 | - | 38,438,691 | 1.38% | 69.74% | 1.45% | 69 | 18.97% | 29 | -40.82% |
| 31 Dec, 18 | 147 | -1.34% | 37,914,117 | -0.48% | 69.30% | 1.43% | 58 | 7.41% | 49 | 6.52% |
| 30 Sep, 18 | 149 | 0.68% | 38,097,272 | -3.30% | 69.64% | 1.34% | 54 | -20.59% | 46 | 6.98% |
| 30 Jun, 18 | 148 | 2.78% | 39,398,781 | -0.01% | 72.03% | 1.39% | 68 | 6.25% | 43 | -8.51% |
| 31 Mar, 18 | 144 | -0.69% | 39,402,898 | 3.02% | 72.07% | 1.05% | 64 | -12.33% | 47 | 34.29% |
| 31 Dec, 17 | 145 | -7.64% | 38,248,768 | -6.32% | 82.82% | 0.94% | 73 | -20.65% | 35 | 45.83% |
| 30 Sep, 17 | 157 | 45.37% | 40,828,161 | 31.83% | 94.02% | 1.85% | 92 | 104.44% | 24 | -25.00% |
| 30 Jun, 17 | 108 | -14.96% | 30,969,159 | 5.63% | 71.33% | 1.56% | 45 | -8.16% | 32 | -15.79% |
| 31 Mar, 17 | 127 | -6.62% | 29,319,174 | -2.70% | 67.58% | 1.39% | 49 | -37.97% | 38 | 40.74% |
| 31 Dec, 16 | 136 | -11.11% | 30,132,835 | 8.03% | 69.69% | 1.68% | 79 | 19.70% | 27 | -35.71% |
| 30 Sep, 16 | 153 | 3.38% | 27,893,424 | -8.66% | 64.49% | 1.29% | 66 | -25.84% | 42 | 50.00% |
| 30 Jun, 16 | 148 | 12.98% | 30,536,354 | 3.78% | 70.62% | 1.52% | 89 | 12.66% | 28 | -15.15% |
| 31 Mar, 16 | 131 | -5.76% | 29,425,164 | 3.15% | 68.12% | 1.09% | 79 | 5.33% | 33 | -19.51% |
| 31 Dec, 15 | 139 | 0.72% | 28,527,266 | 2.37% | 79.09% | 1.27% | 75 | -16.67% | 41 | 24.24% |
| 30 Sep, 15 | 138 | 45.26% | 27,866,465 | 54.18% | 78.90% | 2.96% | 90 | 40.63% | 33 | 94.12% |
| 30 Jun, 15 | 95 | 28.38% | 18,074,474 | 6.60% | 51.64% | 1.70% | 64 | 18.52% | 17 | 54.55% |
| 31 Mar, 15 | 74 | 57.45% | 16,955,528 | 38.80% | 55.09% | 3.03% | 54 | 157.14% | 11 | -35.29% |
| 31 Dec, 14 | 47 | -2.08% | 12,215,761 | 0.99% | 42.64% | 2.52% | 21 | -16.00% | 17 | 21.43% |
| 30 Sep, 14 | 48 | -12.73% | 12,095,832 | 0.07% | 41.17% | 2.41% | 25 | -44.44% | 14 | 100.00% |
| 30 Jun, 14 | 55 | 57.14% | 12,087,115 | 9.50% | 41.29% | 2.38% | 45 | 28.57% | 7 | - |
| 31 Mar, 14 | 35 | - | 11,038,114 | - | 41.69% | - | 35 | - | - | - |
Intra-Cellular Therapies Insider Shareholders Trades
Open Market Insider Trades
Open Market Insider Buys
| Date | Name | Relation | Role | Transaction | Buy/Sell | Shares | Price | Value | Shares Held | Source |
|---|
Insider Sells
All Insider Owners Trades
The last insider sell of Intra-Cellular Therapies's stock was made by VAN NOSTRAND ROBERT L on Jun 25 2024, selling 1,567 shares at - per share (valued at -).
Intra-Cellular Therapies Insider Ownership Trends
All Insider Trades Trend
| Date | Buy | Sell | Buy/Sell Ratio |
|---|---|---|---|
| Q3 2024 | 2 | - | - |
| Q2 2024 | 18 | 11 | 163.64% |
| Q1 2024 | 39 | 100 | 39.00% |
| Q4 2023 | 5 | 8 | 62.50% |
| Q3 2023 | 3 | 6 | 50.00% |
| Q2 2023 | 15 | 9 | 166.67% |
| Q1 2023 | 30 | 64 | 46.88% |
| Q4 2022 | 3 | 7 | 42.86% |
| Q3 2022 | 5 | 9 | 55.56% |
| Q2 2022 | 12 | 6 | 200.00% |
| Q1 2022 | 27 | 67 | 40.30% |
| Q4 2021 | 10 | 26 | 38.46% |
| Q3 2021 | 4 | 1 | 400.00% |
| Q2 2021 | 11 | 9 | 122.22% |
| Q1 2021 | 28 | 43 | 65.12% |
| Q4 2020 | 12 | 18 | 66.67% |
| Q3 2020 | 7 | 3 | 233.33% |
| Q2 2020 | 12 | 7 | 171.43% |
| Q1 2020 | 30 | 40 | 75.00% |
| Q4 2019 | 10 | 6 | 166.67% |
2 total buy trades, and 0 total sell trades (buy/sell ratio of 0%) were made by Intra-Cellular Therapies's insiders, as of Q3 2024.
Open Market Insider Trades Trend
| Date | Buy | Sell | Buy/Sell Ratio |
|---|---|---|---|
| Q3 2024 | - | - | - |
| Q2 2024 | - | 3 | - |
| Q1 2024 | - | 73 | - |
| Q4 2023 | - | 5 | - |
| Q3 2023 | - | 5 | - |
| Q2 2023 | - | 4 | - |
| Q1 2023 | - | 47 | - |
| Q4 2022 | - | 6 | - |
| Q3 2022 | - | 5 | - |
| Q2 2022 | - | 4 | - |
| Q1 2022 | - | 51 | - |
| Q4 2021 | - | 18 | - |
| Q3 2021 | - | - | - |
| Q2 2021 | - | 5 | - |
| Q1 2021 | - | 28 | - |
| Q4 2020 | - | 7 | - |
| Q3 2020 | 2 | 1 | 200.00% |
| Q2 2020 | - | 4 | - |
| Q1 2020 | - | 22 | - |
| Q4 2019 | - | 3 | - |
As of Q3 2024, Insider owners conducted 0 open market buy trades and 0 open market sell trades of Intra-Cellular Therapies's stocks.
Intra-Cellular Therapies Peer Ownership
| Ticker | Company |
|---|---|
| ANIP | ANI Pharmaceuticals, Inc. |
| AMRX | Amneal Pharmaceuticals, Inc. |
| AQST | Aquestive Therapeutics, Inc. |
| DVAX | Dynavax Technologies Corporation |
| NBIX | Neurocrine Biosciences, Inc. |
| IRWD | Ironwood Pharmaceuticals, Inc. |
| DCPH | Deciphera Pharmaceuticals, Inc. |
| CYTH | Cyclo Therapeutics, Inc. |
| ALKS | Alkermes plc |
| PCRX | Pacira BioSciences, Inc. |
| COLL | Collegium Pharmaceutical, Inc. |
| EGRX | Eagle Pharmaceuticals, Inc. |
| AMPH | Amphastar Pharmaceuticals, Inc. |
ITCI Ownership FAQ
Who Owns Intra-Cellular Therapies?
Intra-Cellular Therapies is owned by institutional shareholders (10.48%), insiders (2.34%), and public (87.18%). The largest institutional shareholder of Intra-Cellular Therapies is FMR LLC (11.60% of total shares) and the top mutual fund owner is Manager Directed Portfolios (2.32% of total shares).
Who are the major institutional shareholders of Intra-Cellular Therapies?
Intra-Cellular Therapies's major institutional shareholders are FMR LLC, VANGUARD GROUP INC, BLACKROCK INC., WASATCH ADVISORS LP, and JPMORGAN CHASE & CO. The top five shareholders own together 35.43% of the company's share outstanding.
How many Intra-Cellular Therapies shareholders are there?
As of Jun 2024, there are 138 institutional shareholders of Intra-Cellular Therapies.
What percentage of Intra-Cellular Therapies is owned by FMR LLC?
FMR LLC owns 11.24M shares of Intra-Cellular Therapies, representing 11.60% of the company's total shares outstanding, valued at $769.68M (as of Jun 2024).
What percentage of Intra-Cellular Therapies is owned by VANGUARD GROUP INC?
As of Jun 2024, VANGUARD GROUP INC holds 9.61M shares of Intra-Cellular Therapies (ITCI), compromising 9.92% of the company, valued at $657.98M.
What percentage of Intra-Cellular Therapies is owned by BLACKROCK INC?
BLACKROCK INC is the third largest holder of Intra-Cellular Therapies. The company owns 6.32M of the company's shares outstanding (worth $432.97M).